Annual Drug Patent Expirations for LASTACAFT
Lastacaft is a drug marketed by Allergan and is included in one NDA. It is available from one supplier. There are two patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for LASTACAFT.
This drug has forty-two patent family members in thirty countries.
The generic ingredient in LASTACAFT is alcaftadine. One supplier is listed for this compound. Additional details are available on the alcaftadine profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com